Growth Metrics

Catheter Precision (VTAK) Acquisitions (2023 - 2026)

Catheter Precision (VTAK) reported Acquisitions of $1.2 million for Q1 2026, up 101.67% on a QoQ basis from -$72.5 million in Q4 2023.

Catheter Precision (VTAK) has 2 years of Acquisitions data on file, last reported at $1.2 million in Q1 2026.

  • Quarterly Acquisitions changed N/A year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (changed N/A YoY) and the FY2023 annual result came in at $15000.0, changed N/A from the prior year.
  • Acquisitions grew to $1.2 million in Q1 2026 per VTAK's latest filing, from -$72.5 million in the prior quarter.
  • Across five years, Acquisitions topped out at $72.6 million in Q3 2023 and bottomed at -$72.5 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Catheter Precision 2.01 Mn 1.20 Mn 390,000.00 1.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.21 Mn
Dec 31, 2023 -72.53 Mn
Sep 30, 2023 72.56 Mn
Mar 31, 2023 -15,000.00